A Smartphone App Designed to Help Cancer Patients Stop Smoking: Results From a Pilot Randomized Trial on Feasibility, Acceptability, and Effectiveness
Open accessPublished version of a preprint
The DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.
Abstract
Background: Persistent smoking after a cancer diagnosis predicts worse treatment outcomes and mortality, but access to effective smoking cessation interventions is limited. Smartphone apps can address this problem by providing a highly accessible, low-cost smoking cessation intervention designed for patients with a recent cancer diagnosis. Objective: This study aimed to summarize our development process and report the trial design, feasibility, participant acceptability, preliminary effectiveness, and impact on processes of change (eg, cancer stigma) of the first-known smoking cessation smartphone app targeted for cancer patients. Methods: We used an agile, user-centered design framework to develop a fully automated smartphone app called Quit2Heal that provided skills training and stories from cancer survivors focusing on coping with internalized shame, cancer stigma, depression, and anxiety as core triggers of smoking. Quit2Heal was compared with the National Cancer Institute’s QuitGuide, a widely used stop smoking app for the general population, in a pilot double-blinded randomized trial with a 2-month follow-up period. Participants were 59 adult smokers diagnosed with cancer within the past 12 months and recruited through 2 cancer center care networks and social media over a 12-month period. The most common types of cancer diagnosed were lung (21/59, 36%) and breast (10/59, 17%) cancers. The 2-month follow-up survey retention rate was 92% (54/59) and did not differ by study arm (P=.15). Results: Compared with QuitGuide participants, Quit2Heal participants were more satisfied with their assigned app (90% [19/21] for Quit2Heal vs 65% [17/26] for QuitGuide; P=.047) and were more likely to report that the app assigned to them was made for someone like them (86% [18/21] for Quit2Heal vs 62% [16/26] for QuitGuide; P=.04). Quit2Heal participants opened their app a greater number of times during the 2-month trial period, although this difference was not statistically significant (mean 10.0, SD 14.40 for Quit2Heal vs mean 6.1, SD 5.3 for QuitGuide; P=.33). Self-reported 30-day point prevalence quit rates at the 2-month follow-up were 20% (5/25) for Quit2Heal versus 7% (2/29) for QuitGuide (odds ratio 5.16, 95% CI 0.71-37.29; P=.10). Quit2Heal participants also showed greater improvement in internalized shame, cancer stigma, depression, and anxiety, although these were not statistically significant (all P>.05). Conclusions: In a pilot randomized trial with a high short-term retention rate, Quit2Heal showed promising acceptability and effectiveness for helping cancer patients stop smoking. Testing in a full-scale randomized controlled trial with a longer follow-up period and a larger sample size is required to test the effectiveness, mediators, and moderators of this promising digital cessation intervention. Trial Registration: ClinicalTrials.gov NCT03600038; https://clinicaltrials.gov/ct2/show/NCT03600038
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“With a sample of 422 (211 in each arm), wherein missing outcome data is imputed as smoking, if we observe a 13.6% 30-day PPA at the 12-month follow-up in the Quit2Heal arm and a 4.7% 30-day PPA at the 12-month follow-up in the QuitGuide arm, we will have at least 80% power to detect a clinically meaningful difference in smoking cessation between treatment arms.”
From Efficacy of smartphone applications to help cancer patients quit smoking: Protocol of the Quit2Heal randomized controlled trial (2023) · cites this paper as [28]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These estimates are based on the self-reported quit rates at the 2-month follow-up observed in the Quit2Heal pilot trial, relapse by 12 months, and participant outcome data attrition.28,61–63”
From Efficacy of smartphone applications to help cancer patients quit smoking: Protocol of the Quit2Heal randomized controlled trial (2023) · cites this paper as [28]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“our research team followed an agile, user-centered design framework27 to develop the first known smartphone app (called “Quit2Heal”) specifically designed to help cancer patients quit smoking.28”
From Efficacy of smartphone applications to help cancer patients quit smoking: Protocol of the Quit2Heal randomized controlled trial (2023) · cites this paper as [28]
The cited source says what the claim attributes to it.
In the citing paper
“Self-reported 30-day point prevalence abstinence (PPA) rates were 20% for Quit2Heal vs. 7% for QuitGuide (OR=5.16; 95% CI: 0.71-37.29; p=.10) at the 2-month follow-up.”
From Efficacy of smartphone applications to help cancer patients quit smoking: Protocol of the Quit2Heal randomized controlled trial (2023) · cites this paper as [28]
The cited source says what the claim attributes to it.
In the citing paper
“Compared to QuitGuide participants, Quit2Heal participants showed greater improvements in shame, stigma, depression, and anxiety, albeit not statistically significant (all p>.05).”
From Efficacy of smartphone applications to help cancer patients quit smoking: Protocol of the Quit2Heal randomized controlled trial (2023) · cites this paper as [28]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Brief Measure for Assessing Generalized Anxiety Disorder: The GAD-7
Spitzer, R. L., Kroenke, K., Williams, J. B. W., & Löwe, B. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.10.1092 · Cited by 31,765
Modern Applied Statistics with S
Venables, W. N., & Ripley, B. D. (2002) · Statistics and Computing · doi:10.1007/978-0-387-21706-2 · Cited by 24,305
The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire
HEATHERTON, T. F., KOZLOWSKI, L. T., FRECKER, R. C., & FAGERSTROM, K. (1991) · British Journal of Addiction · doi:10.1111/j.1360-0443.1991.tb01879.x · Cited by 10,738 · cited 3×
“1 | e16652 | p. 7http://formative.jmir.org/2020/1/e16652/ (page number not for citation purposes) XSL•FO RenderX P valueQuit2Heal (N=29)a QuitGuide (N=30)a Total (N=59)a 4 (1/26)24 (5/21)13 (6/47)IV .235.3 (3.3)4.2 (3.7)4.7 (3.5)Months since initial diagnosis, mean (SD) Type of standard cancer treatment completed, % (…”
BackgroundMethodInfluentialScreening for Depression in Well Older Adults: Evaluation of a Short Form of the CES-D
Andresen, E. M., Malmgren, J. A., Carter, W. B., & Patrick, D. L. (1994) · American Journal of Preventive Medicine · doi:10.1016/s0749-3797(18)30622-6 · Cited by 5,403
Andresen, E. M., Malmgren, J. A., Carter, W. B., & Patrick, D. L. (1994) · PubMed · Cited by 4,426
Biochemical verification of tobacco use and cessation
Benowitz, N. L., III, P. J., Ahijevych, K., Jarvis, M. J., Hall, S., LeHouezec, J., Hansson, A., Lichtenstein, E., Henningfield, J., Tsoh, J., et al. (2002) · Nicotine & Tobacco Research · doi:10.1080/14622200210123581 · Cited by 1,800
Prevalence of depression in patients with cancer
Massie, M. J. (2004) · Journal of the National Cancer Institute Monographs · doi:10.1093/jncimonographs/lgh014 · Cited by 1,408 · cited 1×
“Building on the promise of apps for the general population of smokers, a targeted intervention can address the unique processes that impede cessation among cancer patients, including shame about being a smoker, cancer stigma (feeling socially rejected for having caused one’s cancer), depression, and anxiety [35-44].”
BackgroundHEATHERTON, T. F., KOZLOWSKI, L. T., FRECKER, R. C., RICKERT, W., & ROBINSON, J. (1989) · British Journal of Addiction · doi:10.1111/j.1360-0443.1989.tb03059.x · Cited by 1,313 · cited 1×
“We used computer-generated randomly permuted block randomization, stratified by Heaviness of Smoking Index (score>4 [55]), confidence in being smoke-free >70 (on a scale of 0-100), and recruitment method”
MethodMobile phone-based interventions for smoking cessation
Whittaker, R., McRobbie, H., Bullen, C., Rodgers, A., & Gu, Y. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006611.pub4 · Cited by 1,079 · cited 1×
“These sociodemographic groups are typically underrepresented in eHealth and mHealth smoking cessation research [73], although they experience significant disparities in the prevalence and negative health consequences of smoking [74].”
BackgroundTelephone counselling for smoking cessation
Stead, L. F., Hartmann-Boyce, J., Perera, R., & Lancaster, T. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002850.pub3 · Cited by 1,003 · cited 3×
“Self-reported smoking is a standard method for assessing the efficacy of low-intensity interventions [68,69].”
BackgroundMethod
Research works printed but not linked: 1
- Luna, D, 2015, Stud Health Technol Inform, 216, 967
Cited by
Challenges in Participant Engagement and Retention Using Mobile Health Apps: Literature Review
Amagai, S., Pila, S., Kaat, A. J., Nowinski, C. J., & Gershon, R. C. (2022) · Journal of Medical Internet Research · doi:10.2196/35120 · Cited by 343
Prutzman, Y. M., Wiseman, K. P., Grady, M. A., Budenz, A., Grenen, E. G., Vercammen, L. K., Keefe, B., & Bloch, M. (2021) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2020.08.008 · Cited by 57
Lung cancer stigma and depression: validation of the lung cancer stigma inventory
Ostroff, J. S., Riley, K. E., Shen, M. J., Atkinson, T. M., Williamson, T. J., & Hamann, H. A. (2019) · Psycho-Oncology · doi:10.1002/pon.5033 · Cited by 54
Self-citationKiss, N. K., Jongebloed, H., Baguley, B. J., Marshall, S., WHITE, V. M., Livingston, P. M., Bell, K., Young, L., Sabesan, S. S., Swiatek, D., et al. (2024) · JNCI Cancer Spectrum · doi:10.1093/jncics/pkae048 · Cited by 51
Mobile health interventions for cancer patient education: A scoping review
Samadbeik, M., Garavand, A., Aslani, N., Sajedimehr, N., & Fatehi, F. (2023) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2023.105214 · Cited by 35
Metadata
- Authors
- Bricker, J. B., Watson, N. L., Heffner, J. L., Sullivan, B., Mull, K., Kwon, D., Westmaas, J. L., & Ostroff, J.
- Affiliations
- University of Washington (US)
- Fred Hutch Cancer Center (US)
- American Cancer Society (US)
- Corresponding author
- Bricker, Jonathan B
- ORCID
- Venue
- JMIR Formative Research
- Publisher
- JMIR Publications Inc.
- Published
- 2020-01-17
- Volume
- 4
- Issue
- 1
- Pages
- e16652
- ISSN
- 2561-326X (ISSN-L)
- PMC
- PMC6996729
- OpenAlex
- W2996162400
- Cited by
- 41
- References
- 69
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 9 · 2023: 9 · 2022: 12 · 2021: 2 · 2020: 2
- FWCI
- 2.92
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- JMIR Formative Research (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Institute on Drug Abuse (R01DA038411)
- National Cancer Institute (R01CA192849, R01CA166646)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
- Health Sciences › Health Professions › General Health Professions › Mobile Health and mHealth Applications
- Social Sciences › Psychology › Applied Psychology › Digital Mental Health Interventions
- Keywords
- smoking cessation, cancer patients, mobile application, cancer stigma, internalized shame, user-centered design, cancer survivors, lung cancer, breast cancer, mobile health intervention, app engagement, user-generated content, coping skills training
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
